10-Year Anniversary of First Total Marrow Irradiation Delivery with the TomoTherapy® System Illustrates Growing Impact of Groundbreaking Approach SUNNYVALE, Calif. , June 9, 2015 /PRNewswire/ -- This month marks the 10-year anniversary of the first successful total marrow irradiation (TMI) using
SUNNYVALE, Calif. , July 21, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patients treated with the TomoTherapy® System.
SUNNYVALE, Calif., June 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated (Nasdaq: TOMO) by Accuray.
Availability of Industry-Leading Radiosurgery System at Japan’s Foremost Cancer Center Extends Accuray’s Market Share in Japan SUNNYVALE, Calif. , Feb. 27, 2012 /PRNewswire/ Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced installation of the CyberKnife®
System is Designed to Improve Treatment Results, Minimize Treatment Impact on Patients' Quality of Life SUNNYVALE, Calif. , Dec. 12, 2019 /PRNewswire/ -- Timpanogos Cancer Services made history in Utah recently with the installation of the state's first Radixact ® System , the next-generation
SUNNYVALE, Calif. , Jan. 17, 2019 /PRNewswire/ -- According to the American Cancer Society , prostate cancer is the most common cancer in American men other than skin cancer. Accuray Incorporated (NASDAQ: ARAY) and The Urology Group (TUG) are partnering to recognize TUG's commitment to improving
Where experience and state-of-the-art technology meet SUNNYVALE, Calif. , April 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the European CyberKnife Center Munich-Grosshadern (ECZM) has performed 5,000 CyberKnife® treatments since June 2005 .
Next-Generation "Smart" TomoTherapy® System Represents Major Step Forward in Treatment Speed, Ease of Use and Adaptive Therapy Capabilities SUNNYVALE, Calif. , Feb. 8, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has received Shonin approval from the Japanese
Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care SUNNYVALE, Calif. , Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the
First Multi-System Agreement by a Hospital for Both Accuray and RaySearch Products The Swiss Medical Network, Accuray and RaySearch Have Also Partnered to Expand Opportunities for Training Healthcare Professionals on the Latest Technologies SUNNYVALE, Calif.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
